EUVIMEDEUVIMED entdecken
Open Access

County-Level Factors Associated with Reversal of Insurer-Approved HIV Pre-Exposure Prophylaxis Prescriptions in the United States, 2018

Rahel Dawit, William C Goedel, Hsien-Yen Chang, Amy S Nunn, Philip A Chan, Jalpa A Doshi, Lorraine T Dean

AIDS and Behavior · 2025

DOI: 10.1007/s10461-024-04585-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS and Behavior, 2025. Verfasst von Rahel Dawit und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. rdawit1@jhu.edu. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, HIV Infections, Anti-HIV Agents, Drug Prescriptions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Health, Center for AIDS Research, Johns Hopkins University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-Exposure ProphylaxisHIV InfectionsAnti-HIV AgentsDrug PrescriptionsMedication AdherenceHumansUnited StatesMaleFemaleAdultMiddle AgedInsurance, Health

Stichwörter der Autor:innen

County-level socioeconomic factorsHIV/AIDSPrEP reversal

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. rdawit1@jhu.edu.
  • Department of Epidemiology, Brown University, Providence, RI, USA.
  • Janssen Pharmaceutical Companies, Titusville, NJ, USA.
  • Department of Behavioral and Social Sciences, Brown University, Providence, RI, USA.
  • Brown University AIDS Program, The Miriam Hospital, Providence, RI, 02906, USA.
  • Division of Infectious Diseases, Department of Medicine, Alpert Medical School of Brown University, Providence, RI, 02903, USA.

Förderung

  • NIAID NIH HHS
  • National Institute of Health
  • Center for AIDS Research, Johns Hopkins University
  • NINR NIH HHS

Zitieren

APA

Dawit, R., Goedel, W. C., Chang, H. Y., Nunn, A. S., Chan, P. A., Doshi, J. A., & Dean, L. T. (2025). County-Level Factors Associated with Reversal of Insurer-Approved HIV Pre-Exposure Prophylaxis Prescriptions in the United States, 2018. AIDS and Behavior. https://doi.org/10.1007/s10461-024-04585-8

Vancouver

Dawit R, Goedel WC, Chang HY, Nunn AS, Chan PA, Doshi JA, et al. County-Level Factors Associated with Reversal of Insurer-Approved HIV Pre-Exposure Prophylaxis Prescriptions in the United States, 2018. AIDS and Behavior. 2025. doi:10.1007/s10461-024-04585-8

BibTeX
@article{Dawit2025,
  author = {Dawit, Rahel and Goedel, William C and Chang, Hsien-Yen and Nunn, Amy S and Chan, Philip A and Doshi, Jalpa A and Dean, Lorraine T},
  title = {County-Level Factors Associated with Reversal of Insurer-Approved HIV Pre-Exposure Prophylaxis Prescriptions in the United States, 2018},
  journal = {AIDS and Behavior},
  year = {2025},
  doi = {10.1007/s10461-024-04585-8}
}
Kostenlos starten →